IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, cilt.16, sa.3, ss.205-218, 2017 (SCI-Expanded)
Bone marrow-derived mesenchymal stem cells (BMSCs) can ameliorate a variety of lung diseases such as asthma, lung fibrosis, and acute lung injury by its anti-inflammatory and immunmodulatory effects. In this study, we developed a mouse model of bronchiolitis obliterans (BO) and evaluated the effects of the intraperitoneal administration of BMSCs on lung histopathology and cytokine levels.